CLBT — Cellebrite DI Ltd.
—
Nasdaq ·
Information Technology ·
Software ·
CIK 1854587 ·
Last close
$10.65
Market Cap
$2.68B
52W High
$19.39
52W Low
$9.58
ADV30
2,054,553
Next earnings
2027-02-10
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 149,022,000 | 121,047,000 | 26,875,000 | 26,656,000 | 1,068,486,000 | 223,055,000 | 489,179,000 |
| Jun 2026 | 131,138,000 | 105,931,000 | 6,949,000 | 6,371,000 | 994,311,000 | 141,250,000 | 456,214,000 |
| Mar 2026 | 128,301,000 | 105,881,000 | 9,119,000 | 10,938,000 | 952,286,000 | 133,689,000 | 441,746,000 |
| Dec 2025 | 128,821,000 | 109,130,000 | 20,805,000 | 21,261,000 | 938,852,000 | 124,457,000 | 454,534,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$157,557,000
Investing CF
$-209,644,000
Financing CF
$14,726,000
CapEx
$-29,006,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.22
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-69,229,000
Inventory
$8,388,000
Receivables
$110,782,000
ST Investments
$301,281,000
EBIT TTM
$80,584,000
Pretax Income TTM
$75,380,000
Interest Exp TTM
—
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$514,288,992
EBITDA
$78,427,000
Free Cash Flow
$124,924,376
Enterprise Value
$2,397,024,000
Total Cash
$442,531,008
Total Debt
$23,229,000
Shares Out
251,341,060
Trailing EPS
$0.23
Book Value
$2.15
ROE
12.4%
ROA
3.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 475,675,000 | 66,480,000 | 78,326,000 | 938,852,000 | 454,534,000 | 484,318,000 | 173,544,000 |
| Dec 2024 | 401,203,000 | 56,906,000 | -283,007,000 | 690,567,000 | 354,547,000 | 336,020,000 | 132,171,000 |
| Dec 2023 | 325,110,000 | 33,237,000 | -81,100,000 | 532,885,000 | 498,673,000 | 34,212,000 | 102,058,000 |
| Dec 2022 | 270,651,000 | 1,044,000 | 120,805,000 | 403,293,000 | 329,428,000 | 73,865,000 | 20,577,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.65
Max Pain — expiry 2026-12-18
max pain strike: $12.50 · spot: $11.16 · call oi: 6,815 · put oi: 3,290
Expected Move to 2026-12-18:
±$1.60
(14.34%) —
implied range
$9.56 –
$12.76
· ATM straddle on $10.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| FSLY | Fastly, Inc. | $2.56B | $15.90 | — |
| SPSC | SPS COMMERCE INC | $2.84B | $80.03 | — |
| KVYO | Klaviyo, Inc. | $2.88B | $22.10 | — |
| NCNO | nCino, Inc. | $2.34B | $22.09 | — |
| BLKB | BLACKBAUD INC | $2.32B | $51.69 | — |
News headlines (Yahoo Finance, 1h cache)
Cellebrite: 3 Key Takeaways for Long-Term Investors
2026-11-15 03:03 · Yahoo
Cellebrite (CLBT) Stock Could Be Undervalued As Cash Flow Builds
2026-11-14 18:08 · Yahoo
Cellebrite DI (CLBT) Appoints Rogerio Rizzi As EVP For Corporate Strategy And Development
2026-11-14 17:05 · Yahoo
Cellebrite DI (CLBT) Slides On Guidance Reset As Undervalued Narrative Faces A Test
2026-11-14 16:06 · Yahoo
Earnings Beat May Recast The Case For Cellebrite Stock
2026-11-14 15:09 · Yahoo
Cellebrite DI Ltd. Q3 2026 Earnings Call Summary
2026-11-13 13:30 · Yahoo
Cellebrite (CLBT) Q3 2026 Earnings Call Transcript
2026-11-13 00:29 · Yahoo
Cellebrite DI Q3 Earnings Call Highlights
2026-11-12 17:15 · Yahoo
Cellebrite Reports Third-Quarter 2026 Results
2026-11-12 12:00 · Yahoo
Cellebrite to Report Third-Quarter 2026 Financial Results on November 12, 2026
2026-11-09 13:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.